Pages
Products
AAV5-hSyn-FLuc

AAV5-hSyn-FLuc

Cat.No. :  AAV00512Z

Titer: ≥1x10^12 GC/mL / ≥1x10^13 GC/mL Size: 30 ul/100 ul/500 ul/1 ml

Serotype:  AAV Serotype 5 Storage:  -80 ℃

Inquire for Price

AAV Particle Information

Quality Control

Cat. No. AAV00512Z
Description AAV serotype 5 particles express firefly luciferase (FLuc) reporter gene under the control of human Synapsin promoter for neuronal specific expression.
Reporter FLuc
Serotype AAV Serotype 5
Target Gene FLuc
Application

1. Determination of optimal MOI (multiplicity of infection), administration methods etc.

2. Detection of the infection efficiency of the AAV serotype against a specific cell type or tissue.

3. Using reporter genes to visualize the distribution and expression of AAV vectors in live animals, helping assess the biodistribution and persistence of gene delivery.

Titer Varies lot by lot, typically ≥1x10^12 GC/mL
Size Varies lot by lot, for example, 30 μL, 50 μL, 100 μL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance.
Purity AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE.
Sterility The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities.
Empty vs. Full Capsids Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods.
Quick Inquiry

Background

Publications

Q & A

Customer Reviews

Adeno-associated virus (AAV) belongs to the Parvoviridae family and primarily infects mammalian cells and is reportedly non-pathogenic to humans. AAV was first reported in 1965 as a contaminant of adenovirus and has since been identified as naturally replication-defective, requiring a helper virus such as adenovirus for propagation. The linear single-stranded DNA genome of AAV (approximately 4.7 kb) encodes two genes, rep and cap, flanked by inverted terminal repeats (ITRs), which are required for packaging of the viral genome into capsids. The ITRs are primers for second-strand synthesis and are the only elements of the genome that require cis sequences during viral production. For the production of recombinant adeno-associated virus (rAAV) vectors, the remaining viral genome can be removed, placed in trans on a separate plasmid, and then replaced with the desired transgene. The rep gene encodes four overlapping nonstructural proteins required for replication, integration, and packaging. Rep78 and Rep68 bind to the ITRs and have helicase and endonuclease activities necessary for AAV genome replication. Rep52 and Rep40 have 3' to 5' helicase activity and package the viral genome into capsids during virus production. The cap gene encodes three structural proteins, VP1, VP2, and VP3, which self-assemble into a 60-mer icosahedral capsid in a ratio of approximately 1:1:10. The three proteins are transcribed from the same open reading frame and share a C-terminal domain but have different N-termini due to alternative start codons and alternative splicing. cap also encodes a nonstructural protein, assembly activation protein (AAP), which is located in an alternative open reading frame to VP that was initially shown to be required for AAV2 capsid assembly. The dependence of AAP on capsid assembly is serotype specific, as AAV4, -5, and -11 do not require AAP for assembly. rAAV achieves high levels of long-term gene expression without chromosomal integration and exists episomally in the nucleus as head-to-tail ligands. rAAV episomes may be able to replicate in proliferating cells, albeit at a lower frequency.
Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Excellent customer support

We were impressed with the fast delivery and excellent customer support from Creative Biogene. Their team provided valuable guidance on optimizing our in vivo experiments with AAV5-hSyn-FLuc.

Germany

04/13/2024

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction